Indexed keywords
ARTICLE;
DRUG COST;
DRUG DEVELOPMENT;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MARKETING;
FALSE NEGATIVE RESULT;
FALSE POSITIVE RESULT;
BIOMEDICAL RESEARCH;
COSTS AND COST ANALYSIS;
DRUG DISCOVERY;
DRUG INDUSTRY;
EFFICIENCY, ORGANIZATIONAL;
MODELS, THEORETICAL;
1
16944363243
More haste, less development speed
D. Lendrem More haste, less development speed Scrip Mag. 1995 22 23
(1995)
Scrip Mag. , pp. 22-23
Lendrem, D.1
2
0032721152
Alternative strategies in drug development: Clinical pharmacological aspects
J. Kuhlmann Alternative strategies in drug development: clinical pharmacological aspects Int. J. Clin. Pharmacol. Ther. 37 1999 575 583
(1999)
Int. J. Clin. Pharmacol. Ther. , vol.37
, pp. 575-583
Kuhlmann, J.1
3
33947691728
Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development
DOI 10.1016/j.drudis.2007.02.004, PII S1359644607000566
R. Peck Driving earlier clinical attrition; if you want to find the needle, burn down the Haystack Drug Discov. Today 12 2007 289 294 (Pubitemid 46486663)
(2007)
Drug Discovery Today , vol.12
, Issue.7-8
, pp. 289-294
Peck, R.W.1
4
84888280580
Quick win, fast fail
C. Clarke Quick win, fast fail Int. Clin. Trials 13 2010 142
(2010)
Int. Clin. Trials , vol.13
, pp. 142
Clarke, C.1
5
77649234756
How to improve R&D productivity
S. Paul How to improve R&D productivity Nat. Rev. Drug Discov. 9 2010 203 214
(2010)
Nat. Rev. Drug Discov. , vol.9
, pp. 203-214
Paul, S.1
6
0030449652
Some statistical issues in project prioritization in the pharmaceutical industry
S.J. Senn Some statistical issues in project prioritization in the pharmaceutical industry Stat. Med. 15 1996 2689 2702
(1996)
Stat. Med. , vol.15
, pp. 2689-2702
Senn, S.J.1
7
84875692383
Stochastic models for the planning of pharmaceutical research
J.C. Gittins Stochastic models for the planning of pharmaceutical research J. Stat. Theory Appl. 2 2003 198 214
(2003)
J. Stat. Theory Appl. , vol.2
, pp. 198-214
Gittins, J.C.1
8
34548324706
The cost of biopharmaceutical R&D; Is biotech different?
J.A. DiMasi, and H.G. Grabowski The cost of biopharmaceutical R&D; is biotech different? Manage. Decis. Econ. 28 2007 469 479
(2007)
Manage. Decis. Econ. , vol.28
, pp. 469-479
Dimasi, J.A.1
Grabowski, H.G.2
9
84927978861
The pharmaceutical sector
L.R. Burns, University Press
J. Northrup The pharmaceutical sector L.R. Burns, The Business of Healthcare Innovation 2005 University Press 27 102
(2005)
The Business of Healthcare Innovation , pp. 27-102
Northrup, J.1
10
15844411320
Moving statistics beyond the individual clinical trial: Applying decision science to optimize a clinical development plan
DOI 10.1002/pst.149
S.A. Julious, and D.J. Swank Moving statistics beyond the individual clinical trial: applying decision science to optimize a clinical development plan Pharm. Stat. 4 2005 37 46 (Pubitemid 40425994)
(2005)
Pharmaceutical Statistics , vol.4
, Issue.1
, pp. 37-46
Julious, S.A.1
Swank, D.J.2
